FDA grants Fast Track designation for ARCA biopharma's Gencaro
ARCA biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of GencaroTM, the Company
News-Medical-Net,
Mon Nov 23 06:24:35 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News